March 1, 2017 / 12:20 AM / 7 months ago

BRIEF-Acadia Pharmaceuticals Q4 loss per share $0.65

Feb 28 (Reuters) - Acadia Pharmaceuticals Inc

* Acadia Pharmaceuticals reports financial results for the fourth quarter and year ended december 31, 2016

* Q4 loss per share $0.65

* Q4 earnings per share view $-0.65 -- Thomson Reuters I/B/E/S Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below